These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CgA
129 results:

  • 1. Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study.
    Meng QH; Halfdanarson TR; Bornhorst JA; Jann H; Shaheen S; Shi RZ; Schwabe A; Stade K; Halperin DM
    Clin Cancer Res; 2024 Dec; 30(24):5559-5567. PubMed ID: 39453770
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessing the Risk of Postoperative Delirium Through Comprehensive Geriatric Assessment and Eastern Cooperative Oncology Group Performance Status of Elderly Patients With gastric cancer.
    Itami T; Yamamoto K; Kurokawa Y; Saito T; Takahashi T; Momose K; Yamashita K; Tanaka K; Makino T; Yasunobe Y; Akasaka H; Fujimoto T; Yamamoto K; Nakajima K; Eguchi H; Doki Y
    Ann Surg Oncol; 2024 Dec; 31(13):9039-9047. PubMed ID: 39373928
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. miR-107 reverses the multidrug resistance of gastric cancer by targeting the cga/EGFR/GATA2 positive feedback circuit.
    Wang P; Zhou Y; Wang J; Zhou Y; Zhang X; Liu Y; Li A; He Y; Chen S; Qian A; Wang X; Nie Y; Fan D; Cao T; Lu Y; Zhao X
    J Biol Chem; 2024 Aug; 300(8):107522. PubMed ID: 38960034
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Larger Tumor Size and Elevated Serum Chromogranin A Levels Predict Metastatic Disease on DOTATATE Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
    Labora A; Shimizu T; Moore A; Premji A; Armstrong WR; Chen KY; Link J; Chan CS; Allen-Auerbach MS; Donahue TR
    Ann Surg Oncol; 2024 Oct; 31(10):6875-6882. PubMed ID: 38909116
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Plasma tryptophan pathway metabolites quantified by liquid chromatography-tandem mass spectrometry as biomarkers in neuroendocrine tumor patients.
    Johansen SU; Hansen T; Nordborg A; Meyer R; Goll R; Florholmen J; Jensen E
    J Neuroendocrinol; 2024 Mar; 36(3):e13372. PubMed ID: 38361341
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biomarkers in neuroendocrine neoplasms.
    Zouli C; Zisimopoulou E; Chrisoulidou A
    Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinicopathological features and differential diagnosis of gastric metastases.
    Chen W; Liu C; Liu Y; Yuan J; Wang Z
    World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
    Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
    Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
    Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
    Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]    [Full Text] [Related]  

  • 11. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 12. Expression of 5-HT Relates to Stem Cell Marker LGR5 in Patients with Gastritis and gastric cancer.
    Niu Q; Li L; Zhang C; Qi C; He Q; Zhu Y
    Dig Dis Sci; 2023 May; 68(5):1864-1872. PubMed ID: 36436157
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Chromogranin B in blood serum of patients with neuroendocrine tumors.
    Lyubimova NV; Timofeev YS; Markovich AA; Lebedeva AV; Karamisheva EI; Delektorskaya VV; Kushlinskii NE
    Klin Lab Diagn; 2022 Aug; 67(8):440-443. PubMed ID: 36095079
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A cga/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer.
    Cao T; Lu Y; Wang Q; Qin H; Li H; Guo H; Ge M; Glass SE; Singh B; Zhang W; Dong J; Du F; Qian A; Tian Y; Wang X; Li C; Wu K; Fan D; Nie Y; Coffey RJ; Zhao X
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289315
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes.
    Lu J; Jin M; Zhou X; Chen X; Shao Y; Jiang X
    APMIS; 2022 Mar; 130(3):169-180. PubMed ID: 34862662
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Anticancer Effects of the
    Tosoc JPS; Nuñeza OM; Sudha T; Darwish NHE; Mousa SA
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641577
    [No Abstract]    [Full Text] [Related]  

  • 17. Is Additional Gastrectomy Required for Elderly Patients after Endoscopic Submucosal Dissection with Endoscopic Curability C-2 for Early gastric cancer?
    Hatta W; Gotoda T; Koike T; Uno K; Asano N; Imatani A; Masamune A
    Digestion; 2022; 103(1):83-91. PubMed ID: 34638125
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic value of different lymph node staging methods for node-positive cardia gastric cancer: a register-based retrospective cohort study.
    Wang XQ; Bao M; Zhang C
    BMJ Open; 2021 Aug; 11(8):e050378. PubMed ID: 34426469
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms cga and has surgical and clinical utility.
    Modlin IM; Kidd M; Falconi M; Filosso PL; Frilling A; Malczewska A; Toumpanakis C; Valk G; Pacak K; Bodei L; Öberg KE
    Ann Oncol; 2021 Nov; 32(11):1425-1433. PubMed ID: 34390828
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinicopathological features and survival analysis of gastric cancer patients with neuroendocrine differentiation after radical resection].
    Yu S; Lyu MZ; Luo RK; Liu FL; Liu TS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):426-432. PubMed ID: 34000772
    [No Abstract]    [Full Text] [Related]  

    [Next]

    of 7.